Federico Comoglio
Swiss Institute of Bioinformatics
2 papers found
Refreshing results…
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Download from kar.kent.ac.ukMissing publications? Search for publications with a matching author name.